The largest database of trusted experimental protocols

18 protocols using anti il 6

1

Trypanosoma cruzi Infection and Cytokine Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vero cell monolayers were infected with trypomastigote forms of T. cruzi Tulahuen strain for 3 h and then washed and maintained in RPMI (Gibco Invitrogen Corporation) at 37°C in a 5% CO2 atmosphere. After 7 days, the parasites were collected from the supernatant of infected cells and harvested by centrifugation at 4,400 rpm for 5 min.
Peripheral blood mononuclear cells from non-chagasic donors were cultured with T. cruzi Tulahuen trypomastigotes (1:1 rate) for 3 h, then the cells were washed and cultured with recombinant bioactive IL-6 (20 ng/mL) or with anti-IL-6 (2 µg/mL) (Biolegend) or anti-IL-6 plus anti-IL-1β (2 µg/mL), or maintained in medium alone for 48 h. Then, culture supernatants were evaluated for IL-1β/NO levels, and the cells were analyzed for NT staining or NO production by flow cytometry. In addition, peripheral blood from chagasic patients and control donors (250 µL) were cultured with 7,500 trypomastigotes with or without IL-6 (20 ng/mL) or maintained in medium for 24 h and then cells were harvested to evaluate NO and ROS production and NT by flow cytometry.
+ Open protocol
+ Expand
2

Cytokine Blockade in Murine Models

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were treated i.p. with 150 μg anti-GM-CSF (22E9.11, J. Abrams) [28 (link)], 250 μg anti-CSF-1R (ASF98, S-I Nishikawa) [28 (link)], 150 μg anti-CSF-1 (F. Dodeller, MorphoSys, Munich, Germany) [28 (link), 31 (link)], 750 μg anti-GM-CSFRα (CAM-3003) [11 (link)], 750 μg anti-TNF (MP6-XT22, Biolegend, San Diego, CA, USA), 750 μg anti-IL-6 (Biolegend) and their respective isotype control mAb, at the time points indicated.
+ Open protocol
+ Expand
3

Phenotyping Immune Cells via Flow Cytometry

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated monocytes (105) and PBMCs were incubated with 100 ng/ml LPS (Sigma Aldrich), 5 ng/ml IL-2 (Cell Signaling Technologies), 50 ng/ml phorbol-12-myristate-13-acetate (PMA, Merck), and 1 μg/ml ionomycin (Sigma Aldrich) for 37℃, 5 h, respectively; and GolgiStop (BD Biosciences) was added for the final 3 h. Monocytes were stained with FITC-CD14 and PerCP-CD16 (Biolegend), and PBMCs were stained with FITC-CD45RO, PE-CD4, PerCP-CD3, and APC-CCR7 for 30 min. Cells were fixed and permeabilized using the protocol from the Cytofix/Cytoperm kit (BD Biosciences). Then, the monocytes were stained with anti-TNF-α (Biolegend) and anti-IL-6 (Biolegend), and the PBMCs were stained with anti-IFN-γ (BD Biosciences) and anti-IL-2 (BD Biosciences) for 30 min.
Expression of cell-surface markers was assessed using flow cytometry (FACSCalibur, BD, USA) after gating of live cells, and analyzed according to scatter characteristics using FlowJo software.
+ Open protocol
+ Expand
4

Antibody Panel for Immunophenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used rabbit anti-ESAT-6 antibody (Abcam, Cambridge, MA), mouse anti-His6X antibody (Sigma-Aldrich, St. Louis MA), anti-FLAG antibody (Sigma-Aldrich, St. Louis MA), HRP conjugated anti-mouse IgG (Bio-rad, Hercules, CA), anti-rabbit FITC conjugated secondary antibody (Jackson-ImmunoResearch, West Grove, PA) and anti-mouse Texas Red secondary antibody (Jackson-ImmunoResearch, West Grove, PA) for in vitro studies. For in vivo studies, anti-CD4 (clone: GK1.5)-FITC, -PerCP-Cy5 or -APC, anti-CD8 (clone: 53–6.7)-FITC, -PerCP-Cy5 or -APC, anti-CD44 (clone: IM7)-APC, anti-Brdu (clone: Bu20a)-PE, anti-CD11b (clone: M1/70)-APC, anti-CD11c (clone: N418)-APC, 7AAD, anti-IFN-γ (clone: XMG1.2)-APC, anti-IL-17 (clone: TC11-18H10.1)-PE, anti-IL-4 (clone: 11B11)-PE, anti-IL-6 (clone: MPS-20 F3)-PE, anti-IL-12 (clone: C15.6)-PE, anti-IL-22 (clone: Poly5164)-PE, anti-IL-10 (clone: JES5-16E3)-PE, anti-IL-9 (clone: MH9A4)-PE, anti-TNF-α (clone: MP6-XT22)-PE, (all from Biolegend, USA) and anti-CD69 (clone: H1.2 F3)-PE (from eBiosciences, USA) were used.
+ Open protocol
+ Expand
5

Cytokine Modulation of Cellular Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytokines and cytokine-neutralizing antibodies were added to cultures upon plating of the cells and used at the following concentrations in vitro: VEGF165 (12 ng/mL; catalog no. CYF- 336; Prospec-Bio), TNFα (100 ng/mL; catalog no. 31501A; Pepro-tech), IL6 (100 pg/mL; catalog no. 216–16; PeproTech), anti-TNFα (0.4 μg/mL; catalog no. AF410NA; R&D Systems), universal IFNα (100 U; catalog no. 11200-2; R&D Systems), anti-IL6 (1 μg/mL; catalog no. MP5-20F3; BioLegend), LPS (25 ng/mL; catalog no. L4524; Sigma), and CpG (25 ng/mL; Mayo Clinic Oligonucleotide Core facility).
+ Open protocol
+ Expand
6

Cytokine Detection via ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the detection of cytokines in the cell culture supernatants or sera, ELISAs were performed as described previously [37 (link)], using the primary capture mAbs anti-TNFα, and anti-IL-6 and their corresponding biotinylated detection mAbs (Biolegend, USA). Recombinant mouse TNFα and IL-6 (Biolegend, USA) were used as standards. IL-10 was measured using a commercial ELISA kit (R&D systems, USA) according to manufacturer’s instructions. Other ELISA reagents included: HRP-conjugated avidin D (Vector Laboratories, USA), TMB microwell peroxidase substrate and stop solution (Kirkegaard and Perry Laboratories, USA).
+ Open protocol
+ Expand
7

Recombinant MIF and Antagonist Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human MIF (rhMIF) was prepared as described elsewhere (46 (link)) (endotoxin content < 0.1 EU/ml). MIF antagonist MIF098 [3-(3-hydroxybenzyl)-5-methylbenzooxazol-2-one] was dissolved in DMSO at a concentration of 149 µM (47 (link)). The neutralizing anti-MIF monoclonal antibody (clone NIHlllD.9) was obtained from ascites after purification using protein A/G spin column and resuspended at 5.15 mg/ml (48 (link), 49 (link)). A CD74 blocking antibody (BD Pharmingen, clone LN2), the recombinant human cytokines IL-6, IL-8, IL-1β (BioLegend), and TNFα (MiltenyiBiotec), and the cytokine neutralizing antibodies anti-IL-8 (R&D Systems), anti-IL-6, anti-IL-1β, and anti-TNFα (BioLegend) were obtained.
+ Open protocol
+ Expand
8

Isolation and Modulation of Myeloid-Derived Suppressor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
R848, Pam3CSK4, Celastrol, and Ruxolitinib were purchased from InvivoGen (San Diego, CA, USA) and all human recombinant cytokines were obtained from Miltenyi Biotec (Auburn, CA, USA). CD163 (Clone #GHI/61), CD206 (Clone #15-2), and CD14 (Clone #M5E2) antibodies used to purify or stain human mMDSC, and anti-IL-6 (Clone #MQ2-13A5), anti-IL-10 (Clone #JES3-19F1), anti-IL-12 (Clone #C11.5), anti-TNFα (Clone #Mab1), and anti-IFNγ (Clone #NIB42) utilized to neutralize secreted cytokines were purchased from BioLegend (San Diego, CA, USA) with the exception of CD14 (Clone #MφP9), EGFR (Clone #EGFR.1), and HLA-DR (Clone #G46-6) antibodies (BD Biosciences, Franklin Lakes, NJ, USA) and the marker of active macrophage 25F9 (Clone #eBio25F9, Thermo Scientific, Waltham, MA, USA).
+ Open protocol
+ Expand
9

Multicolor Flow Cytometry for Cell Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
A complete list of antibodies used in the study is reported in Supplementary Table 1. Dead cells were identified using Fixable Viability Dye eFluor® 506 or 450 (Affymetrix, eBiosciences) and excluded from the analysis. For surface staining: cells were incubated in 2% human serum for the blocking of non-specific antibody binding to receptors (10 min, 4 °C) and subsequently stained with directly labelled primary antibodies (30 min, 4 °C) (Supplementary Table 1). For IL-6 intracellular staining: cells were stimulated with LPS (1 μg/mL, Sigma) for 6 h and GolgiPlug (BD Biosciences) was added in the last 5 h of the assay. After staining of surface markers (using directly labelled anti-CD45, anti-CD1c and anti-CD14 Abs), cells were washed, fixed and permeabilized with Cytofix/Cytoperm buffer (BD Biosciences) and stained with FITC-labelled anti-IL-6 (BioLegend). Acquisition was performed on a FACSVerse flow cytometer (BD Biosciences) and FlowJo analysis software (Treestar) was used for data analysis. Fluorescent-activated cell sorting (FACS) was performed using the ARIA SORP (Becton Dickinson, Franklin Lakes, NJ). Anti-CD45, anti-CD1c and anti-CD14 sterile antibodies were used. Briefly, 2 days post-injection tumour-free OSCs and OMCs were digested, under sterile conditions, and the cell suspensions filtered, stained and cells were sorted with >98% purity.
+ Open protocol
+ Expand
10

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
We used the following antibodies: anti-CD4 (clone: GK1.5)-FITC, -PerCP-Cy5, or -APC, anti-CD8 (clone: 53-6.7)-FITC, -PerCP-Cy5, or -APC, anti-CD44 (clone: IM7)-APC, anti-BrdU (clone: Bu20a)-PE, 7AAD, anti-IFN-γ (clone: XMG1.2)-APC, anti-IL-17 (clone: TC11-18H10.1)-PE, anti-IL-4 (clone: 11B11)-PE, anti-IL-6 (clone: MPS-20F3)-PE, anti-IL-12 (clone: C15.6)-PE, anti-IL-22 (clone: Poly5164)-PE, anti-IL-10 (clone: JES5-16E3)-PE, anti-IL-9 (clone: MH9A4)-PE, anti-TNF-α (clone: MP6-XT22)-PE (all from Biolegend, USA), anti-Active Caspase-3 (clone: C92-605)-FITC or -PE (from BD Pharmingen™, USA), and anti-CD69 (clone: H1.2F3)-PE (from eBiosciences, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!